NCT00534183View on ClinicalTrials.gov

Metabolic Profile and Anthropometric Changes in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

2,006

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

December 31, 2006

Conditions
Metabolic SyndromeDiabetesObesity
Interventions
DRUG

Olanzapine

Olanzapine in dose range of 10-20mg

DRUG

Risperidone

Risperidone 1-6mg

DRUG

Haloperidol

Haloperidol 10-20mg

Trial Locations (1)

834009

Central Institute of Psychiatry, Ranchi

All Listed Sponsors
lead

Central Institute of Psychiatry, Ranchi, India

OTHER

NCT00534183 - Metabolic Profile and Anthropometric Changes in Schizophrenia | Biotech Hunter | Biotech Hunter